You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: April 8, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Acotiamide

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Acotiamide?

Acotiamide is an investigational drug.

There have been 4 clinical trials for Acotiamide. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2008.

The most common disease conditions in clinical trials are Dyspepsia, Gastritis, and [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Universitaire Ziekenhuizen Leuven, and Zeria Pharmaceutical.

Recent Clinical Trials for Acotiamide
Effect of Acotiamide on Gastric Motility and Satiation in Healthy VolunteersUniversitaire Ziekenhuizen LeuvenN/A
Phase III, Long-term, Open-label Safety Study of Z-338Zeria PharmaceuticalPhase 3
A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy AdultsAstellas Pharma IncPhase 1

See all Acotiamide clinical trials

Clinical Trial Summary for Acotiamide

Top disease conditions for Acotiamide
Top clinical trial sponsors for Acotiamide

See all Acotiamide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.